Latest Health News
World Health Day 2026: Together for Health, Stand with Science
World Health Day on April 7, 2026, launches a year-long campaign emphasizing scientific collaboration via the One Health approach to protect people, animals, plants, and the planet. Key events include the International One Health Summit hosted by France and the Global Forum of WHO Collaborating Centres gathering 800 institutions from 80 countries.
The campaign aims to rebuild trust in science and support evidence-based solutions.
US Health Clinics Face $32 Billion Loss Under GOP Policies
About 17,000 federally funded health clinics risk losing $32 billion over five years due to GOP-backed fiscal policies in Trump's 'One Big Beautiful Bill Act,' increasing strain as uninsured patients rise. This darkens the outlook for low-cost care access.
Over 400 US Hospitals at Risk from Medicaid Cuts
More than 400 hospitals across the US are at high risk of closure or service cuts due to Medicaid reductions in Trump's bill, per Public Citizen analysis. This threatens care for millions and jobs for health workers, as Medicaid funds a fifth of hospital spending.
NIH Chief Sparks Debate on Vannevar Bush Legacy
NIH Director Jay Bhattacharya claims Trump's policies echo Vannevar Bush's vision for US biomedical research supremacy, provoking outrage in scientific circles. The debate highlights tensions over research policy direction.
Fluvoxamine Reduces Long COVID Fatigue in Trial
Antidepressant fluvoxamine reduced fatigue in long COVID patients short-term versus placebo in a 399-person randomized trial using the Fatigue Severity Scale. Participants had severe fatigue scores of at least four out of seven.
Iterative Health Partners with US Heart & Vascular for CV Research
Iterative Health and US Heart & Vascular announced a strategic partnership on April 2, 2026, to advance community-based cardiovascular research. This aims to foster innovation in heart care.
Seaport Therapeutics Reports Positive Phase 1 Results for GlyphAgo
PureTech-founded Seaport Therapeutics announced positive proof-of-concept topline results from an ongoing Phase 1 trial of GlyphAgo in healthy volunteers on April 2, 2026. This advances their therapeutic pipeline.
FDA Clears IND for CanWell Pharma's CAN016 ADC
FDA cleared the IND for CAN016, a dual-payload HER2-targeting ADC by CanWell Pharma, for Phase 1 in ADC pre-treated solid tumor patients on April 2, 2026. It targets patients with disease progression post prior therapies.
National Medical Association Alarms on Cuba Health Crisis
Cuba faces a public health crisis from energy shortages linked to the blockade, causing power outages disrupting hospitals, surgeries for 96,000 patients, and vaccine storage. Vulnerable groups suffer shortages of antibiotics and supplies, worsening maternal-infant outcomes.
NMA calls for blockade removal elements harming civilians.
WHO Europe Emphasizes One Health for Health Security
World Health Day 2026 promotes One Health to prevent threats, integrating human, animal, and environmental health surveillance amid rising signals like COVID-19 lessons. WHO collaborates with WOAH, FAO, UNEP on joint risk assessments and outbreak responses.
Collaborating centres drive implementation.
Iran War Strains Global Humanitarian Aid
The Iran war is straining humanitarian aid, as detailed in three charts, amid broader global health challenges like Gaza injuries and funding limbo post-USAID cuts. This impacts poverty, migration, and governance in health.
Gilead Accused of Blocking HIV Drug Access
Gilead Sciences refuses to sell HIV prevention drug lenacapavir directly to Doctors Without Borders, accused of blocking global access. This raises concerns over pharmaceutical access in low-resource settings.